Tamra Slone, M.D.

Medical School

University of Alabama at Birmingham School of Med. (2001)

Residency

University of North Alabama (2004), Pediatrics

Fellowship

UT Southwestern/Children's Medical Center (2007), Pediatric Hematology/oncology

• Acute Lymphoblastic Leukemia (ALL)

Featured Publications

Fasting selectively blocks development of acute lymphoblastic leukemia via leptin-receptor upregulation.

Lu Z, Xie J, Wu G, Shen J, Collins R, Chen W, Kang X, Luo M, Zou Y, Huang LJ, Amatruda JF, Slone T, Winick N, Scherer PE, Zhang CC Nat. Med. 2016 Dec

Long-term central venous access in a pediatric leukemia population.

Fu AB, Hodgman EI, Burkhalter LS, Renkes R, Slone T, Alder AC J. Surg. Res. 2016 Oct 205 2 419-25

Novel r(2)(p25q31) Cytogenetic Abnormality in a Pediatric Patient With Acute Leukemia of Ambiguous Lineage.

Kim J, Bu L, Koduru PR, Wilson KS, Fuda FS, Kumar KR, Timmons CF, Slone TL, Luu HS Pediatr. Dev. Pathol. 2014 Dec

Subclinical cardiotoxicity in childhood cancer survivors exposed to very low dose anthracycline therapy.

Leger K, Slone T, Lemler M, Leonard D, Cochran C, Bowman WP, Bashore L, Winick N Pediatr Blood Cancer 2014 Aug

Infantile mixed phenotype acute leukemia (bilineal and biphenotypic) with t(10;11)(p12;q23);MLL-MLLT10.

Lou Z, Zhang CC, Tirado CA, Slone T, Zheng J, Zaremba CM, Oliver D, Chen W Leuk. Res. 2010 Aug 34 8 1107-9

Risk factors for readmission after initial diagnosis in children with acute lymphoblastic leukemia.

Slone TL, Rai R, Ahmad N, Winick NJ Pediatr Blood Cancer 2008 Sep 51 3 375-9

• Best Pediatric Specialists/Doctors in Dallas
  D Magazine (2016) (2018)
• Abstract Reviewer
  49th Annual Meeting of the American Society of Hematology (2007)
• Clinical Research Training Institute, 2006-2007
  American Society of Hematology (2007)
• Housestaff Council, 2001-2004
  Peer-elected (2004)
• Chairman’s Award for Outstanding Intern
  (2002)